Abstract
Purpose
To evaluate safety and efficacy of uterine artery embolization using narrow-size-range polyphosphazene-coated hydrogel microspheres (Embozene, CeloNova Biosciences, Newnan, GA).
Methods
Between May 2006 and September 2008, a total of 121 consecutive patients (mean ± SD age 42.1 ± 5.4 years, range 30.5–51.5 years) were enrolled onto this single-center study. The primary study endpoint was safety as assessed by the society of interventional radiology (SIR) classification. The secondary endpoint was efficacy, which was based on a 1-year magnetic resonance imaging study and relief of symptoms documented by the Medical Outcomes Study 36-Item Short-Form Health Survey questionnaire over a 2-year interval.
Results
The mean ± SD diameter of the dominant fibroid was 6.4 ± 2.6 (range, 2.9–13.9) cm and the mean volume 137.2 ± 245.1 (range, 5.3–1184) ml. Most patients had multiple fibroids with 11% more than 10. A total of 240 of 242 interventions were completed as planned, a technical success rate of 99.2%. According to the SIR classification, one type A, eight type C, and one type D complication occurred. Total devascularization was noted in 96% (116 of 121) of dominant fibroids. Volume decrease was 4% at 2 weeks, 52% (P < 0.001) at 3 months, 78% (P < 0.001) at 6 months, and 91% at 12 months (P < 0.001). The latter difference was statistically significant (P = 0.007). A total of 92% had improved hypermenorrhea at 1 year and 94% at 2 years. Dysmenorrhea was improved in 96% at 1 year and in 95% at 2 years. The overall health status score was 60.4 ± 26.2 points at baseline and 96.9 ± 3.8 after 1 year (P = 0.0019).
Conclusion
Uterine artery embolization with Embozene microspheres is a safe procedure. Its efficacy is demonstrated by high fibroid devascularization and volume reduction rates and significant improvements of clinical symptoms and quality-of-life scores during follow-up.
Similar content being viewed by others
References
Ravina JH, Herbreteau D, Ciraru-Vigneron N et al (1995) Arterial embolisation to treat uterine myomata. Lancet 346:671–672
Spies JB, Allison S, Flick P et al (2004) Polyvinyl alcohol particles and tris-acryl gelatin microspheres for uterine artery embolization for leiomyomas: results of a randomized comparative study. J Vasc Interv Radiol 15:793–800
Spies JB, Ascher SA, Roth AR et al (2001) Uterine artery embolization for leiomyomata. Obstet Gynecol 98:29–34
Richter GM, Radeleff B, Rimbach S, Kauffmann GW (2004) Uterine fibroid embolization with spheric micro-particles using flow guiding: safety, technical success and clinical results. Rofo 176:1648–1657
Siskin GP, Shlansky-Goldberg RD, Goodwin SC et al (2006) A prospective multicenter comparative study between myomectomy and uterine artery embolization with polyvinyl alcohol microspheres: long-term clinical outcomes in patients with symptomatic uterine fibroids. J Vasc Interv Radiol 17:1287–1295
Siskin GP, Englander M, Stainken BF et al (2000) Embolic agents used for uterine fibroid embolization. AJR Am J Roentgenol 175:767–773
Spies JB, Warren EH, Mathias SD et al (1999) Uterine fibroid embolization: measurement of health-related quality of life before and after therapy. J Vasc Interv Radiol 10:1293–1303
Walker WJ, Pelage JP, Sutton C (2002) Fibroid embolization. Clin Radiol 57:325–331
Pelage JP, Le Dref O, Beregi JP et al (2003) Limited uterine artery embolization with tris-acryl gelatin microspheres for uterine fibroids. J Vasc Interv Radiol 14:15–20
Spies JB, Allison S, Flick P et al (2005) Spherical polyvinyl alcohol versus tris-acryl gelatin microspheres for uterine artery embolization for leiomyomas: results of a limited randomized comparative study. J Vasc Interv Radiol 16:1431–1437
Welle A, Grunze M, Tur D (2000) Blood compatibility of poly[bis(trifluoroethoxy)phosphazene]. J Appl Med Polymers 4:6–10
Stampfl S, Stampfl U, Bellemann N et al (2008) Biocompatibility and recanalization characteristics of hydrogel microspheres with polyzene-F as polymer coating. Cardiovasc Intervent Radiol 31:799–806
Stampfl S, Stampfl U, Bellemann N et al (2009) Immunohistochemical characterization of specific inflammatory tissue reactions following embolization with four different spherical agents in the minipig kidney model. J Vasc Interv Radiol 20:936–945
Stampfl U, Stampfl S, Bellemann N et al (2009) Experimental liver embolization with four different spherical embolic materials: impact on inflammatory tissue and foreign body reaction. Cardiovasc Intervent Radiol 32:303–312
Stampfl S, Bellemann N, Stampfl U et al (2009) Arterial distribution characteristics of Embozene particles and comparison with other spherical embolic agents in the porcine acute embolization model. J Vasc Interv Radiol 20:1597–1607
Spies JB, Rundback JH, Ascher S et al (2006) Development of a research agenda for uterine artery embolization: proceedings from a multidisciplinary research consensus panel. J Vasc Interv Radiol 17:1871–1879
Spies JB (2009) What evidence should we demand before accepting a new embolic material for uterine artery embolization? J Vasc Interv Radiol 20:567–570
Golzarian J, Lang E, Hovsepian D et al (2006) Higher rate of partial devascularization and clinical failure after uterine artery embolization for fibroids with spherical polyvinyl alcohol. Cardiovasc Intervent Radiol 29:1–3
Hovsepian DM, Siskin GP, Bonn J et al (2004) Quality improvement guidelines for uterine artery embolization for symptomatic leiomyomata. Cardiovasc Intervent Radiol 27:307–313
Brazier JE, Harper R, Jones NM et al (1992) Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 305:160–164
Leoni CJ, Potter JE, Rosen MP et al (2001) Classifying complications of interventional procedures: a survey of practicing radiologists. J Vasc Interv Radiol 12:55–59
Spies JB, Spector A, Roth AR et al (2002) Complications after uterine artery embolization for leiomyomas. Obstet Gynecol 100:873–880
Marx M, Wack JP, Baker EL et al (2003) Ovarian protection by occlusion of uteroovarian collateral vessels before uterine fibroid embolization. J Vasc Interv Radiol 14:1329–1332
Barth MM, Spies JB (2003) Ovarian artery embolization supplementing uterine embolization for leiomyomata. J Vasc Interv Radiol 14:1177–1182
Kroencke TJ, Scheurig C, Lampmann LE et al (2008) Acrylamido polyvinyl alcohol microspheres for uterine artery embolization: 12-month clinical and MR imaging results. J Vasc Interv Radiol 19:47–57
Walker WJ, Pelage JP (2002) Uterine artery embolisation for symptomatic fibroids: clinical results in 400 women with imaging follow up. BJOG 109:1262–1272
Radeleff BA, Satzl S, Eiers M et al (2007) Clinical 3-year follow-up of uterine fibroid embolization. Rofo 179:593–600
Radeleff B, Eiers M, Bellemann N et al (2010) Expulsion of dominant submucosal fibroids after uterine artery embolization. Eur J Radiol 75:e57–e63
Radeleff B, Rimbach S, Kauffmann GW, Richter GM (2003) Risk and complication rate of uterine fibroid embolization (UFE). Radiologe 43:641–650
Kerlan RK Jr, Coffey JO, Milkman MS et al (2003) Massive vaginal hemorrhage after uterine fibroid embolization. J Vasc Interv Radiol 14:1465–1467
Spies JB, Roth AR, Gonsalves SM, Murphy-Skrzyniarz KM (2001) Ovarian function after uterine artery embolization for leiomyomata: assessment with use of serum follicle stimulating hormone assay. J Vasc Interv Radiol 12:437–442
Kroncke TJ, Gauruder-Burmester A, Gronewold M et al (2004) Technical success rate, peri-interventional complications and radiation exposure of the transarterial embolization for leiomyomas of the uterus. Rofo 176:580–589
Vetter S, Schultz FW, Strecker EP, Zoetelief J (2004) Patient radiation exposure in uterine artery embolization of leiomyomata: calculation of organ doses and effective dose. Eur Radiol 14:842–848
Kroncke TJ, Gauruder-Burmester A, Scheurig C et al (2005) Transarterial embolization for uterine fibroids: clinical success rate and results of magnetic resonance imaging. Rofo 177:89–98
Pelage JP, Guaou NG, Jha RC et al (2004) Uterine fibroid tumors: long-term MR imaging outcome after embolization. Radiology 230:803–809
Spies JB, Bruno J, Czeyda-Pommersheim F et al (2005) Long-term outcome of uterine artery embolization of leiomyomata. Obstet Gynecol 106:933–939
Siskin GP, Beck A, Schuster M et al (2008) Leiomyoma infarction after uterine artery embolization: a prospective randomized study comparing tris-acryl gelatin microspheres versus polyvinyl alcohol microspheres. J Vasc Interv Radiol 19:58–65
Pelage JP (2004) Polyvinyl alcohol particles versus tris-acryl gelatin microspheres for uterine artery embolization for leiomyomas. J Vasc Interv Radiol 15:789–791
Pelage JP (2005) Technical optimization of using polyvinyl alcohol microspheres. J Vasc Interv Radiol 16(suppl):568
Razavi MK, Wolanske KA, Hwang GL et al (2002) Angiographic classification of ovarian artery-to-uterine artery anastomoses: initial observations in uterine fibroid embolization. Radiology 224:707–712
Volkers NA, Hehenkamp WJ, Birnie E et al (2006) Uterine artery embolization in the treatment of symptomatic uterine fibroid tumors (EMMY trial): periprocedural results and complications. J Vasc Interv Radiol 17:471–480
Edwards RD, Moss JG, Lumsden MA et al (2007) Uterine-artery embolization versus surgery for symptomatic uterine fibroids. N Engl J Med 356:360–370
Spies JB, Cornell C, Worthington-Kirsch R et al (2007) Long-term outcome from uterine fibroid embolization with tris-acryl gelatin microspheres: results of a multicenter study. J Vasc Interv Radiol 18:203–207
Pron G, Bennett J, Common A, Wall J et al (2003) The Ontario Uterine Fibroid Embolization Trial. Part 2. Uterine fibroid reduction and symptom relief after uterine artery embolization for fibroids. Fertil Steril 79:120–127
Kim MD, Lee HS, Lee MH et al (2010) Long-term results of symptomatic fibroids treated with uterine artery embolization: in conjunction with MR evaluation. Eur J Radiol 73:339–344
Volkers NA, Hehenkamp WJ, Birnie E et al (2007) Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: 2 years’ outcome from the randomized EMMY trial. Am J Obstet Gynecol 196:519e1–519e11
Lohle PN, Boekkooi FP, Smeets AJ et al (2006) Limited uterine artery embolization for leiomyomas with tris-acryl gelatin microspheres: 1-year follow-up. J Vasc Interv Radiol 17:283–287
Acknowledgment
Financial disclosure: Research grant from CeloNova Biosciences, Newnan, GA, USA.
Conflict of Interest
U.S, S.S. and G.M.R. have received a research grant from and G.M.R. has served as a consultant to CeloNova Biosciences.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Stampfl, U., Radeleff, B., Sommer, C. et al. Midterm Results of Uterine Artery Embolization Using Narrow-Size Calibrated Embozene Microspheres. Cardiovasc Intervent Radiol 34, 295–305 (2011). https://doi.org/10.1007/s00270-010-9986-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-010-9986-8